Development of a new breath collection method for analysing volatile organic compounds from intubated mouse models
A novel pre-clinical method for collecting breath samples from intubated mice is presented, which can be tailored to respiratory disease research. Integrated with gold-standard respiratory mechanics equipment (flexiVent®), the approach captures volatile organic compounds (VOCs) onto industry-standard sorbent tubes, resulting in mouse breath samples that can be transported and analysed through TD-GC-MS and other central lab technologies. Background levels originating from the intubation equipment are shown to be low enough to effectively distinguish on-breath VOCs from background compounds. Quantitative analysis reveals a distinct number of compounds at elevated levels in mouse breath, despite their lower abundance compared to human breath samples. It is proposed that this method provides a route for translating pre-clinical findings and biomarkers into human clinical studies, particularly in the context of respiratory disease.
Authors
- Shane Swann
- Owen Birch
- Julia Greenwood
- Madeleine L. Ball (ORCID: https://orcid.org/0000-0002-6150-0485)
- Max Allsworth
- Hsuan Chou (ORCID: https://orcid.org/0000-0002-8028-225X)
- Abigail Taylor (ORCID: https://orcid.org/0000-0002-2885-5452)
- Billy Boyle
- Elizabeth Crone
- Lara Pocock
- Kerstin Geillinger-Kästle
- Sylvia Blum
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Boehringer Ingelheim (Egypt) (EG)
- Boehringer Ingelheim (South Korea) (KR)
- Owlstone Medical (United Kingdom) (GB)
Publication Details
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1183/13993003.congress-2024.pa1714
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00